Nitric oxide enhancement and blood pressure decrease in patients with metabolic syndrome using soy protein or fish oil;Aumento de óxido nítrico e diminuição da pressão sanguínea em pacientes com síndrome metabólica em uso de proteína de soja ou óleo de peixe

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 54, Issue 6, 2010, Pages 540-545

  Simão, Andreäa Name Colado ^a   Lozovoy, Marcell Alysson Batisti ^b   Simão, Tathiana Name Colado ^c   Dichi, Jane Bandeira ^a   Matsuo, Tiemi ^a   Dichi, Isaias ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSIDADE NORTE DO PARANÁ   (Brazil)

^c Departamento de Nutrição Clínica   (Brazil)

Author keywords

Blood pressure; Fish oil; Metabolic syndrome; Nitric oxide; Soy

Indexed keywords

EID: 77957708491     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302010000600005     Document Type: Article

References (41)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
2. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004;27:2444-2449.
3. Barbosa PJB, Lessa I, Almeida-Filho N, Magalhães LBNC, Araújo J. Critério de obesidade central em população brasileira: impacto sobre a síndrome metabólica. Arq Bras Cardiol. 2006;87:407-414.
4. Salaroli LB, Barbosa GC, Mill JG, Molina MC. Prevalence of metabolic syndrome in population-based study, Vitória, ES-Brazil. Arq Bras Endocrinol Metabol. 2007;51:1143-1152.
5. Souza LJ, Gicovate Neto C, Chalita FEB, et al. Prevalência de obesidade e fatores de risco cardiovascular em Campos, Rio de Janeiro. Arq Bras Endocrinol Metab. 2003;47(6):669-676.
6. Oliveira EP, Souza MLA, Lima MDA. Prevalência de syndrome metabólica em uma área rural no semi-árido baiano. Arq Bras Endocrinol Metab. 2006;50(3):456-465.
7. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willet WC. Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women. Am J Clin Nutr. 2007;85(3):910-918.
8. Jung UJ, Torrejon C, Tighe AP, Deckelbaum RJ. n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects. Am J Clin Nutr. 2008;87(suppl):2003S-2009S.
9. Calder PC. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83(suppl):1505S-1519S.
10. Deckelbaum RJ, Leaf A, Mozaffarian D, Jacobson TA, Harris WS, Akabas SR. Conclusions and recommendations from the symposium, beyond cholesterol: prevention and treatment of coronary heart disease with n-3 fatty acids. Am J Clin Nutr. 2008;87(suppl):2010S-2012S.
11. Taku K, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr. 2007;85:1148-1156.
12. Azadbakht L, Kimiagar M, Mehrabi Y, et al. Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr. 2007;85:735-741.
13. Reynolds K, Chin A, Lees KA, Nguyen A, Bujnowski D, He J. A meta-analysis of soy protein supplementation on serum lipids. Am J Cardiol. 2006;98:633-640.
14. Gelijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002;20:1493-1499.
15. Yang G, Shu X-O, Jin F, et al. Longitudinal study of soy intake and blood pressure among middle-aged and elderly Chinese women. Am J Clin Nutr. 2005;81:1012-1017.
16. Hermann M, Flammer A, Lüscher TF. Nitric oxide in hypertension. J Clin Hypertens. 2006;8(12 Suppl 4):17-29.
17. Woodman RJ, Mori TA, Burke V, et al. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr. 2002;76:1007-1015.
18. Sun YX, Hu SJ, Zhang XH, Sun J, Zhu CH, Zhang ZJ. Plasma levels of vWF and NO in patients with metabolic syndrome and their relationship with metabolic disorders. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2006;35:315-318.
19. Asl SZ, Ghasemi A, Azizi F. Serum nitric oxide metabolites in subjects with metabolic syndrome. Clin Biochem. 2008;41:1342-1347.
20. Jacobs DR Jr. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and high blood cholesterol in adults (Adults Treatment Panel III). JAMA. 2001;285:2486-2497.
21. Olsen SF, Osterdal ML, Salvig JD, et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomized controlled trial. Am J Clin Nutr. 2008;88:167-175.
22. Santana MB, Mandarino MG, Cardoso JR, et al. Association between soy and green tea (camellia sinensis) diminishes hypercholesterolemia and increases total plasmatic antioxidant potential in dyslipidemic subjects. Nutrition. 2008;24:562-568.
23. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005;45:142-161.
24. Guevara I, Iwanejko J, Dembinska-Kiéc A, et al. Determination of nitrito/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta. 1998;274:177-188.
25. Gonzálvez JAN, Benayas CG, Arenas J. Semiautomated measurement of nitrate in bilogical fluids. Clin Chem. 1998;44:679-681.
26. Jenkins DJA, Kendall CWC, Jackson CJC, et al. Effects of highand low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr. 2002;76:365-372.
27. He J, Gu D, Wu X, et al. Effect of soy bean protein on blood pressure: a randomized controlled trial. Arch Intern Med. 2005;143:1-9.
28. Burke V, Hodgson JM, Beilin LJ, Giangiulioi N, Rogers P, Puddey IB. Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives. Hypertension. 2001;38:821-826.
29. Nestel P, Yamashita T, Sasahara T, et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol. 1997;17:3392-3398.
30. Gimenez I, Martinez RM, Lou M, Mayoral JA, Garay RP, Alda JO. Saliuretic action by genistein in the isolated, perfused rat kidney. Hypertension. 1998;31:706-711.
31. Carroll KK. Review of clinical studies on cholesterol-lowering response to soy protein. J Am Diet Assoc. 1991;91:82-87.
32. Sarafidis PA, Bakris GL. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance? Am J Nephrol. 2007;27:44-54.
33. Engler MM, Engler MB, Goodfriend TL, et al. Docosahexaenoic acid is an antihypertensive nutrient that affects aldosterone production in SHR. Proc Soc Exp Biol Med. 1999;221:32-38.
34. Delarue J, Matzinger O, Binnert C, et al. Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metab. 2003;29:289-295.
35. Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, Katan MB. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation. 2005;112:1945-1952.
36. Das UN. Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but why and how? Prostaglandins Leukot Essent Fatty Acids. 2000;63:351-362.
37. Squandrito F, Altavilla D, Morabito N, et al. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilatation in postmenopausal women. Atherosclerosis. 2002;163:339-347.
38. Smitzko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. New markers of inflammation and endothelial cell activation: Part I. Circulation. 2003;108:1917-1923.
39. Nyby MD, Abedi K, Eslami P, et al. Dietary fish oil prevents hypertension, oxidative stress and suppression of endothelial nitric oxide synthase expression in fructose-fed rats. Am J Hypertens. 2004;17:216A.
40. Erdman JW Jr. AHA Science Advisory: soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition Committee on the AHA. Circulation. 2000;102:2555-2559.
41. Bai Y, Lun S, Yang T, Sun K, Chen J, Hui R. Increase in fasting vascular endothelial function after short-term oral Larginine is effective when baseline flow-mediated dilatation is low: a meta-analysis of randomized trials. Am J Clin Nutr. 2009;89:77-84.